Hyphens Pharma International Ltd. · SGX:1J5
Hyphens Pharma International — Investor Presentation (May 2019)
18 slides from Hyphens Pharma International's investor presentation, May 17, 2019
Slide 1: Singapore's Leading Specialty Pharmaceutical and Consumer Healthcare Group
17/5/2019 SINGAPORE’S LEADING SPECIALTY PHARMACEUTICAL AND CONSUMER HEALTHCARE GROUP HYPHENS PHARMA INTL LTD (SGX: 1J5) DISCLAIMER This presentation has been prepared by Hyphens Pharma International Limited (the "Company" and, together with its subsidiaries, the "Group"). This content in this presen
Slide 2: Company Snapshot
17/5/2019 COMPANY SNAPSHOT ON LISTED ON 18 MAY THE 2018 SGX-CATALIST 3 CORE 2018 REVENUE 5 COUNTRIES BUSINESSES S$121 MILLION 450 PERSONNEL 14 of our products are sold every minute! OUR BUSINESS SEGMENTS Specialty Pharma Principals Proprietary Brands Medical Hypermart and Digital 2
Slide 3: Specialty Pharma Principals
17/5/2019 SPECIALTY PHARMA PRINCIPALS What We Do 1. We handle specialised products, under exclusive agreements with our principals, mainly from Europe. 2. We register and hold product licenses with local authorities. 3. We promote these products through medical representatives to specialists and GPs
Slide 4: Contrast Media Products; Other Specialty Pharma Products
17/5/2019 CONTRAST MEDIA PRODUCTS GUERBET – XENETIX® DOTAREM® LIPIODOL® Our products are used for: • X-Rays • CT Scans • MRI Participation in Scientific Congresses years of working 25 relationship 2018 Revenue Contribution: 13.7% Booth Presence Symposiums OTHER SPECIALTY PHARMA PRODUCTS Intervention
Slide 5: ENT & Allergy Proprietary Brands
17/5/2019 ENT (EAR, NOSE, THROAT) & ALLERGY PROPRIETARY BRANDS What We Do 1. We are the product owner, and the world is our market. 2. We engage in product development. 3. We contract manufacture these products, which bear our trademarks. 5
Slide 6: Brands We Own; We Market Our Brands In
17/5/2019 BRANDS WE OWN WE MARKET OUR BRANDS IN Bangladesh Hong Kong Oman Myanmar Philippines Cambodia Vietnam Malaysia Brunei Singapore Indonesia Direct Presence, Marketing & Distribution Network Marketing & Distribution Network 6
Slide 7: Atopic Dermatitis Range
17/5/2019 ATOPIC DERMATITIS RANGE Gentle Non-Soap Wash Maintenance Therapy Enriched with Essential Skin Lipids in a pH Balanced System * NEW! Specially-Formulated Triple Protective Action Menthol Gel to Calm & Ceramide-Dominant Mosquito Repellent For AD Against Diaper Rash Soothe Itchy Skin Therapeu
Slide 8: Atopic Dermatitis Treatment Market Size
17/5/2019 ATOPIC DERMATITIS TREATMENT MARKET SIZE (USD) Market Report from Future Market Insights, 2017 Global: $5.8B Global: $24B ASEAN $596M ASEAN $210M CLINICALLY TESTED PRODUCTS • Clinical collaborations with KK Women’s and Children’s Hospital and National Skin Centre on Ceradan® regimen • Publi
Slide 9: TDF Derma Formula
17/5/2019 TDF® DERMA FORMULA HOME CARE OILY & ACNE DRY & SENSITIVE HYPER- PIGMENTATION AGE DEFENSE CHEMICAL PEEL LAUNCHED THIS YEAR! LIGHTENS 3 DARK SPOTS IN MONTHS1 XCELAREV® A PATENTED DELIVERY SYSTEM2 WELL TOLERATED WITH LONG-TERM USE1 1 Based on data on file 2 Patent No.: UK GB 2549418 9
Slide 10: Omega-3 Marketing Activities
17/5/2019 MARKETING ACTIVITIES A WELL-REGARDED BRAND BY CONSUMERS Strengths: Brand that I can trust# Good value for money# WINNER WINNER Guardian Health & Watsons Beauty Awards HWB Award since 2008 since 2007 * WINNER Unity Popular WINNER Superbrands Status SINGAPORE’S NO. 1OMEGA-3 Choice Award sinc
Slide 11: Nutritional Supplements
17/5/2019 NUTRITIONAL SUPPLEMENTS Clinical Series is a professional range of health supplement products to meet the clinical nutrition needs of patients Added with vitamins 10 billion LIVE bacteria B, D and zinc in Kids formula Uses VIVOMIXX™ formula PLAY ON 11
Slide 12: Medical Hypermart and Digital
17/5/2019 A DOMINANT BRAND WIDELY DISTRIBUTED Poster at Bus Stops Islandwide MEDICAL HYPERMART AND DIGITAL What We Do 1. We are a wholesaler of pharmaceutical products and medical supplies. 2. We cater largely to private clinics and pharmacies. 3. We have > 3,000 customers and > 4,000 items in our i
Slide 13: Medical Hypermart and Digital
17/5/2019 MEDICAL HYPERMART AND DIGITAL 1st pharmaceutical wholesaler in Singapore to establish an online platform and capture new digital opportunities MORE THAN YEARS HERITAGE BRAND Over 1,500 members on our online Medical Hypermart! 13
Slide 14: Corporate Updates
17/5/2019 CORPORATE UPDATES 1Q2019 27 OFFICIAL OPENING Positive feedback from invited guests Wide media coverage Strong boost in Hyphens branding 28 14
Slide 15: MOU Signing Ceremony; SGX Publications
17/5/2019 MOU SIGNING CEREMONY R&D collaboration activities for dermatologicals & cosmeceuticals with A*ccelerate Target eczema, acne and pigmentary disorders Review of new technologies with several development projects underway 29 SGX PUBLICATIONS 15
Slide 16: Financial Highlights
17/5/2019 FINANCIAL HIGHLIGHTS 31 FINANCIAL HIGHLIGHTS Revenue (S$’m) Profit After Tax (S$’m) 6.1 112.7 120.9 101 5.2 5.4 5.1 78.3 FY2015 FY2016 FY2017 FY2018 FY2015 FY2016 FY2017 FY2018 16
Slide 17: Revenue Segment Breakdown by Business & Geography
17/5/2019 REVENUE SEGMENT BREAKDOWN BY BUSINESS & GEOGRAPHY FY18 Revenue Breakdown by FY18 Revenue Breakdown by Business (S$’m) Geography (S$’m) Medical Hypermart & Digital Others 6.7 (5.5%) 38.4 7.7 (6.4%) (31.7%) 53.9 69.4 (44.5%) (57.4%) 52.7 13.2 (43.6%) (10.9%) Proprietary Specialty Pharma Bran
Slide 18: Share Statistics
17/5/2019 IPO Price SHARE STATISTICS S$0.26 With Market Capitalisation of S$78m SGX Closing Price Stock Code on 7 May 2019 Cornerstone Investors 1J5 S$0.215 @ IPO Market Bloomberg Capitalisation Stock Code S$64.5m Nikko Asset Management HYP:SP (P/E approx. Qilin Asset Management 11.9x) Maxi-Harvest
Hyphens Pharma International — Investor Presentation (May 2019) on 6ix